Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2015 Sep 18;59(10):6648–6652. doi: 10.1128/AAC.01371-15

Antischistosomal Activity of Oxindolimine-Metal Complexes

Josué de Moraes a,, Bruno S Dario b, Ricardo A A Couto b, Pedro L S Pinto c, Ana M da Costa Ferreira b
PMCID: PMC4576111  PMID: 26239976

Abstract

In recent years, a class of oxindole-copper and -zinc complex derivatives have been reported as compounds with efficient proapoptotic activity toward different tumor cells (e.g., neuroblastomas, melanomas, monocytes). Here we assessed the efficacy of synthesized oxindole-copper(II), -zinc(II), and -vanadyl (VO2+) complexes against adult Schistosoma mansoni worms. The copper(II) complexes (50% inhibitory concentrations of 30 to 45 μM) demonstrated greater antischistosomal properties than the analogous zinc and vanadyl complexes regarding lethality, reduction of motor activity, and oviposition.

TEXT

Schistosomiasis (also known as bilharzia) is a major neglected tropical disease caused by blood-dwelling flatworms of the genus Schistosoma (1). It is the second most important human parasitic disease after malaria, with more than 200 million people infected and over 250,000 deaths annually (2, 3). Despite considerable efforts over the past decades, only one efficient and safe drug is currently available, namely, praziquantel {RS-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one}. The development of resistance raises concerns about the urgent need for alternative drugs to control this neglected disease in the long term (4). Therefore, new efficient antischistosomal compounds should be developed.

During recent years, despite a lack of interest from the pharmaceutical industry, considerable efforts have been made to develop novel schistosomicidal agents. As a result, many compounds with promising antischistosomal properties have been identified by academia (5). Among these, piplartine (piperlongumine) and curcumin have also been described as promising anticancer agents (6, 7). Additionally, artemisinin and its derivatives, some of the most interesting antischistosomal compounds, have also been shown to exhibit anticancer properties (8). Thus, the discovery and development of anticancer compounds with antischistosomal properties should be pursued.

Metal-containing drugs (metallodrugs) have long been used as antitumor drugs (9, 10). In recent laboratory studies, some metal ligands have been designed. For example, copper(II) complexes with isatin or imine ligands derived from isatin were prepared, characterized by analytical and spectroscopic techniques, and verified to have biological activity toward the proliferation of different cell types (e.g., human neuroblastoma and promonocytic cells) (11). Subsequently, two new synthesized isatin-Schiff base copper(II) complexes, obtained from isatin and 1,3-diaminopropane or 2-(2-aminoethyl)pyridine, namely, [Cu(isapn)]2+ and [Cu(isaepy)2]2+, respectively, have been reported to exert proapoptotic activity dependent on oxidative stress induction and organelle-selective damage. They were able to transport copper into the cell, producing reactive oxygen species (ROS), and could behave as delocalized, lipophilic, cation-like molecules, thus specifically targeting organelles (12). In addition, the metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2]2+ triggers apoptosis in SH-SY5Y cells through induction of the AMP-activated protein kinase/p38MAPK/p53 signaling axis (13).

In this study, a series of oxindolimine-metal complexes, [Cu(isapn)](ClO4)2 (complex 1), [Cu(isaepy)2](ClO4)2 (complex 2), the corresponding oxindolimine-zinc(II) complexes [Zn(isapn)](ClO4) (complex 3) and [Zn(isaepy)Cl2] (complex 4), and the vanadyl complex [VO(isapn)]SO4 (complex 5), were tested for potential schistosomicidal properties. The copper(II) and zinc(II) oxindolimine complexes (compounds 1 to 4 in Fig. 1A), derived from 2,3-dioxoindole and 2-(2-aminoethyl)pyridine or 1,3-diaminopropane, have already been prepared and characterized in previous studies (11, 14). The corresponding vanadyl complex (compound 5 in Fig. 1A) was prepared according to an equivalent procedure. Most of these complexes have been previously described, and their chemical, physical, and biological properties have been characterized (11, 14, 15). They exhibit tautomeric complexes, related to keto-enol equilibria in solution, dependent on the pH (Fig. 1B). In some cases, the keto form was isolated in solid state; in others, the enol form was isolated. In solution at physiological pH 7.4, both complexes can be present. In the case of isaepy complexes, the enol form is leading, while in the case of isapn complexes, the keto-enol form is predominant at this pH.

FIG 1.

FIG 1

Chemical structures of oxindolimine-metal complexes as isolated (A) and tautomeric equilibria exemplified for oxindolimine-copper(II) complexes 1 and 2 (B).

Schistosoma mansoni strain BH was obtained from an experimentally infected rodent host and intermediate snail host Biomphalaria glabrata in accordance with the standard procedures used in our laboratory (16). For in vitro studies, schistosomes were collected from the hepatic portal and mesenteric veins of an infected hamster 7 weeks postinfection (17). Freshly harvested parasites were placed in Roswell Park Memorial Institute (RPMI) 1640 culture medium supplemented with 10% fetal bovine serum (Vitrocell, Campinas, SP, Brazil) and containing 200 IU/ml penicillin and 200 μg/ml streptomycin at 37°C and 5% CO2 until use. One pair of worms was added to the wells of a 24-well culture plate (TPP, St. Louis, MO, USA) containing the aforementioned RPMI 1640 medium (18, 19). The metal complexes were dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO) to obtain final test concentrations of 31.25 to 1,000 μM (31.25, 62.5, 125, 250, and 500 μM) in culture plates with a final volume of 2 ml. Each compound was tested at least in triplicate, and the highest concentration of DMSO (0.5%) served as a control. Cultures were incubated at 37°C and 5% CO2, and the parasites were kept for 120 h and monitored every 24 h with an inverted microscope. The effect of the drug was assessed with emphasis on viability, alteration of the tegument, and oviposition (18, 20, 21). Moreover, the effects of oxindolimine-metal complexes on the tegument of adult S. mansoni were observed with a confocal laser scanning microscope (LSM 510 META; Carl Zeiss, Göttingen, Germany) (18, 22, 23). Finally, these investigations were also complemented by cytotoxicity studies with Vero cells (CCL-81; ATCC, Manassas, VA) according to a previously described procedure (24). In these experiments, compound toxicity was determined by using a concentration range of 125 to 500 μM (125, 250, and 500 μM).

Oxindolimine-metal complexes exhibit antischistosomal properties dependent on the metal and on the ligand.

The 50% inhibitory concentrations (IC50s) of all of the complexes tested are summarized in Table 1. Anthelmintic activity against adult schistosomes was observed during incubation with complexes 1 to 4. In general, copper complex 1 with the isapn ligand (IC50 of 31.25 μM) and copper complex 2 with the isaepy ligand (IC50 of 46.87 μM) demonstrated higher antischistosomal activity than analogous zinc complexes 3 (IC50 of 156.25 μM) and 4 (IC50 of 187.5 μM) with the same ligands. Because metal complexes with the isapn ligand were the most potent compounds against S. mansoni adults, we further analyzed the effects of this ligand with a vanadyl complex, complex 5, on these worms. However, the vanadyl complex was unable to promote parasite death, even at the highest concentration used (500 μM).

TABLE 1.

In vitro anthelmintic activities of oxindolimine-metal complexes on adult S. mansoni worms

Compound Incubation period (h) IC50 (μM)a
Complex 1 24 78.12 (74.46–81.22)
72 39.06 (37.03–41.58)
120 31.25 (28.65–33.79)
Complex 2 24 89.28 (86.38–93.03)
72 93.75 (74.46–81.22)
120 46.87 (43.24–49.83)
Complex 3 24 NDb
72 187.5 (177.79–195.84)
120 156.25 (148.67–164.92)
Complex 4 24 ND
72 208.33 (193.67–220.03)
120 187.5 (177.79–195.84)
Complex 5 24 ND
72 ND
120 ND
a

IC50s were calculated by using sigmoid dose-response curves; 95% confidence intervals are in parentheses.

b

ND, not determined (because the compound did not show antischistosomal activity at the highest concentration tested [500 μM]).

Severe tegumental damage induced in S. mansoni by oxindolimine-metal complexes.

In addition to the in vitro schistosomicidal effects described above, confocal laser scanning microscopy analysis revealed morphological changes when schistosomes were exposed to compounds 1 to 4, compared to the control group. Adult worms belonging to the control group showed an intact surface structure and topography (Fig. 2A). In contrast, with copper complexes as an example, after exposure to compound 1 at a concentration of 62.5 μM, male worms exhibited moderate tegumental disruption, with shortening of the tubercles (Fig. 2B). When the concentration of compound 1 was increased to 125 μM (Fig. 2C) or 250 μM (Fig. 2D), parasites revealed extensive tegumental destruction, resulting in swelling, sloughing, and erosion of the surface. When schistosomes were exposed to compound 2 at a concentration of 62.5 μM, they exhibited minimal morphological changes, but shrinking of the surface was evident (Fig. 2E). The tegument showed a roughened appearance and started to disintegrate when schistosomes were exposed to compound 2 at 125 μM (Fig. 2F). When the concentration of compound 2 was increased to 250 μM, as with compound 1, severe tegumental alterations were observed, resulting in swelling, sloughing, and erosion of the surface (Fig. 2G).

FIG 2.

FIG 2

Confocal laser scanning microscopy investigation of male S. mansoni worms after in vitro incubation with copper(II) complexes. Shown are control worms showing intact tubercles (Tu) (A) and schistosomes treated with complex 1 at 62.5 μM (B), 125 μM (C), or 250 μM (D) or complex 2 at 62.5 μM (E), 125 μM (F), or 250 μM (G). Parasites exhibiting tubercle shortening (Ts), swelling (Sw), sloughing (Sl), erosion (Er), shortening of the surface (Ss), and tubercle disintegration (Td). Bars, 50 μm.

The tegumental outer surface of schistosomes is a unique double-membrane structure that is of crucial importance for parasite survival; thus, it is a prime target for drug studies. In this context, alterations of the tegument of S. mansoni induced by several antischistosomal compounds have also been described (2529). In this study, we observed extensive tegumental damage in S. mansoni that intensified progressively when the concentrations of the oxindolimine-metal complexes tested increased. The results showed that the schistosomicidal activity of metal complexes is associated with both metals and ligands. Indeed, experiments with oxindole-containing copper complexes have demonstrated the best activity against adult S. mansoni. Additionally, except with the vanadyl complex, which was inactive, schistosomes were more sensitive to isapn ligands than to isaepy ligands. It is known that bioactivity on tumor cells lines is modulated by metal complexes and ligands (12, 30). For example, it has been shown that [Cu(isapn)]2+ and [Cu(isaepy)2]2+, as lipophilic cationic complexes, cross the cell membrane and selectively induce oxidative stress. In this case, [Cu(isaepy)2]2+ seems to be incorporated into cells more efficiently than [Cu(isapn)]2+. In contrast, [Cu(isapn)]2+ is more effective as an upstream ROS inducer (12). With respect to different metals, it has been shown that cells were more susceptible to apoptosis when treated with copper [Cu(isaepy)2]2+ than when treated with zinc [Zn(isaepy)2]2+ (30). The mechanism(s) by which metal complexes exert their antischistosomal activity remains unclear, but taken together, the results show that both metal complexes with copper and those with zinc easily cross the cell membrane and induce severe tegumental damage in schistosomes.

Oxindolimine-metal complexes significantly reduced S. mansoni egg production.

During continuous incubation with all of the oxindolimine-metal complexes at sublethal concentrations, the S. mansoni worms remained coupled. However, the total number of eggs laid by the surviving worms was significantly lower (P < 0.05 to P < 0.001) than that of control worms. All of the helminth couples of the negative-control group showed normal viability, and parasites remained paired and active throughout the treatment period. Interestingly, all of the compounds tested, including the vanadyl complex, were able to reduce oviposition, but there were differences among them. For example, no eggs were seen when parasites were exposed to complex 1 at ≥32.45 μM, complex 2 at ≥62.5 μM, or complex 5 at ≥62.5 μM, whereas the number of eggs was reduced by ∼95% and 30 to 60% by complex 3 at 125 μM and complex 4 at 125 μM, respectively (Fig. 3; data not shown).

FIG 3.

FIG 3

Effects of copper(II) complexes at sublethal concentrations on the daily egg output of paired adult S. mansoni worms. Panels: A, complex 1; B, complex 2. The values are the mean values ± the standard deviations (bars) of 10 paired worms. Statistical tests were performed with the GraphPad Prism software. Significant differences were determined by applying Tukey's test for multiple comparisons. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (compared with untreated groups).

Similar to the results regarding schistosomicidal effects, our data showed that the reduction of S. mansoni egg production is also associated with the nature of both the metal and the ligand used. In this context, the copper complexes were more effective than the zinc complexes in reducing egg output, whereas metal complexes were more efficient with the isapn ligand than with the isaepy ligand. On the other hand, the vanadyl complex, which had not shown a schistosomicidal effect, also affected oviposition of the parasites and was even more efficient than the zinc complexes. Therefore, these results clearly show the importance of the presence of a metal coordinated with a ligand.

Oxindolimine-metal complexes displayed no cytotoxic effect on Vero cells.

An ideal antiparasitic agent is supposed to selectively kill parasites without harming the host. We thus evaluated the cytotoxic effects of all of our oxindolimine-metal complexes on a mammalian cell line (Vero cells). Interestingly, cells treated with any of the oxindolimine-metal compounds at 125, 250, or 500 μM remained viable and showed no significant toxicity (data not shown). Since compounds 1 and 2 exhibit interesting antischistosomal properties, this finding points toward the existence of appreciable selectivity of oxindolimine-metal complexes against S. mansoni.

Conclusions.

Oxindolimine-metal complexes have already shown proapoptotic properties against neuroblastoma, melanoma, and monocyte tumor cells on the basis of DNA binding and mitochondrial damage. They have also been shown to be able to efficiently inhibit human topoisomerase IB (14). Here, some oxindolimine-metal complexes were investigated for the first time as potential schistosomicidal agents. Metal complexes, especially copper(II) complexes, showed significant antischistosomal properties, inducing severe tegumental damage and a significant decrease in the production of eggs. The observed anthelmintic activity was verified to be very dependent on the nature and concentration of the metal complex. Further, this activity was significantly influenced by the ligand. These findings support the potential of oxindolimine-metal complexes as new lead compounds against schistosomes. Nevertheless, further studies should be launched to evaluate the probable mechanism(s) of action, as well as to verify the in vivo efficacy of some metal complexes by using mice harboring S. mansoni.

ACKNOWLEDGMENTS

This work was partially supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2011/50318-1), the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 573530/2008-4), the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and the Pro-Reitoria de Pesquisa da Universidade de São Paulo (PRP-USP 2011.1.9352.1.8). A.M.D.C.F. is also a member of INCT Redoxoma (FAPESP/CNPq/CAPES), NAP Redoxoma (PRPUSP), and CEPID Redoxoma (FAPESP 2013/07937-8). J.D.M. receives no public funding. We are indebted to Henrique K. Roffato and Ronaldo Z. Mendonça (Butantan Institute, São Paulo, SP, Brazil) for expert assistance with confocal microscopy (FAPESP 00/11624-5).

We thank Jefferson S. Rodrigues for maintenance of the S. mansoni life cycle at the Adolfo Lutz Institute (São Paulo, SP, Brazil).

REFERENCES

  • 1.Colley DG, Bustinduy AL, Secor WE, King CH. 2014. Human schistosomiasis. Lancet 383:2253–2264. doi: 10.1016/S0140-6736(13)61949-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D. 2003. Quantification of clinical morbidity associated with schistosome infection in Sub-Saharan Africa. Acta Trop 86:125–139. doi: 10.1016/S0001-706X(03)00029-9. [DOI] [PubMed] [Google Scholar]
  • 3.Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. 2006. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425. doi: 10.1016/S1473-3099(06)70521-7. [DOI] [PubMed] [Google Scholar]
  • 4.Cioli D, Pica-Mattoccia L, Basso A, Guidi A. 2014. Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 195:23–29. doi: 10.1016/j.molbiopara.2014.06.002. [DOI] [PubMed] [Google Scholar]
  • 5.de Moraes J. 2015. Natural products with antischistosomal activity. Future Med Chem 7:801–820. doi: 10.4155/fmc.15.23. [DOI] [PubMed] [Google Scholar]
  • 6.Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. 2013. Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci 48:453–463. doi: 10.1016/j.ejps.2012.12.003. [DOI] [PubMed] [Google Scholar]
  • 7.Troselj KG, Kujundzic RN. 2014. Curcumin in combined cancer therapy. Curr Pharm Des 20:6682–6696. doi: 10.2174/1381612820666140826154601. [DOI] [PubMed] [Google Scholar]
  • 8.Hooft van Huijsduijnen R, Guy RK, Chibale K, Haynes RK, Peitz I, Kelter G, Phillips MA, Vennerstrom JL, Yuthavong Y, Wells TN. 2013. Anticancer properties of distinct antimalarial drug classes. PLoS One 8:e82962. doi: 10.1371/journal.pone.0082962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Komeda S, Casini A. 2012. Next-generation anticancer metallodrugs. Curr Top Med Chem 12:219–235. doi: 10.2174/156802612799078964. [DOI] [PubMed] [Google Scholar]
  • 10.McQuitty RJ. 2014. Metal-based drugs. Sci Prog 97:1–19. doi: 10.3184/003685014X13898980185076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cerchiaro G, Aquilano K, Filomeni G, Rotilio G, Ciriolo MR, Ferreira AM. 2005. Isatin-Schiff base copper(II) complexes and their influence on cellular viability. J Inorg Biochem 99:1433–1440. doi: 10.1016/j.jinorgbio.2005.03.013. [DOI] [PubMed] [Google Scholar]
  • 12.Filomeni G, Cerchiaro G, da Costa Ferreira AM, De Martino A, Pedersen JZ, Rotilio G, Ciriolo MR. 2007. Pro-apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J Biol Chem 282:12010–12021. doi: 10.1074/jbc.M610927200. [DOI] [PubMed] [Google Scholar]
  • 13.Filomeni G, Cardaci S, da Costa Ferreira AM, Rotilio G, Ciriolo MR. 2011. Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment. Biochem J 437:443–453. doi: 10.1042/BJ20110510. [DOI] [PubMed] [Google Scholar]
  • 14.Katkar P, Coletta A, Castelli S, Sabino GL, Couto RA, Ferreira AM, Desideri A. 2014. Effect of oxindolimine copper(II) and zinc(II) complexes on human topoisomerase I activity. Metallomics 6:117–125. doi: 10.1039/C3MT00099K. [DOI] [PubMed] [Google Scholar]
  • 15.Cerchiaro G, Menicke GA, Tavares MFM, da Costa Ferreira AM. 2004. Kinetic studies of carbohydrate oxidation catalyzed by novel isatin-Schiff base copper(II) complexes. J Mol Catal A Chem 221:29–39. doi: 10.1016/j.molcata.2004.06.017. [DOI] [Google Scholar]
  • 16.de Moraes J. 2012. Antischistosomal natural compounds: present challenges for new drug screens, p 333–358. In Rodriguez-Morales AJ. (ed), Current topics in tropical medicine. InTech, Rijeka, Croatia. [Google Scholar]
  • 17.Smithers SR, Terry RJ. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adults worms. Parasitology 55:695–700. [DOI] [PubMed] [Google Scholar]
  • 18.de Moraes J, de Oliveira RN, Costa JP, Junior AL, de Sousa DP, Freitas RM, Allegretti SM, Pinto PL. 2014. Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease schistosomiasis mansoni. PLoS Negl Trop Dis 8:e2617. doi: 10.1371/journal.pntd.0002617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Carvalho AA, Mafud AC, Pinto PL, Mascarenhas YP, de Moraes J. 2014. Schistosomicidal effect of the anti-inflammatory drug diclofenac and its structural correlation with praziquantel. Int J Antimicrob Agents 44:372–374. doi: 10.1016/j.ijantimicag.2014.06.018. [DOI] [PubMed] [Google Scholar]
  • 20.Silva MP, Oliveira GL, de Carvalho RB, de Sousa DP, Freitas RM, Pinto PL, de Moraes J. 2014. Antischistosomal activity of the terpene nerolidol. Molecules 19:3793–3803. doi: 10.3390/molecules19033793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.de Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. 2013. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Schistosoma mansoni schistosomula and adult worms. Curr Med Chem 20:301–309 doi: 10.2174/092986713804806694. [DOI] [PubMed] [Google Scholar]
  • 22.de Moraes J, Carvalho AA, Nakano E, de Almeida AA, Marques TH, Andrade LN, de Freitas RM, de Sousa DP. 2013. Anthelmintic activity of carvacryl acetate against Schistosoma mansoni. Parasitol Res 112:603–610. doi: 10.1007/s00436-012-3172-7. [DOI] [PubMed] [Google Scholar]
  • 23.de Moraes J, Silva MP, Ohlweiler FP, Kawano T. 2009. Schistosoma mansoni and other larval trematodes in Biomphalaria tenagophila (Planorbidae) from Guarulhos, São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo 51:77–82. doi: 10.1590/S0036-46652009000200004. [DOI] [PubMed] [Google Scholar]
  • 24.Silva AP, Silva MP, Oliveira CG, Monteiro DC, Pinto PL, Mendonça RZ, Costa Júnior JS, Freitas RM, de Moraes J. 2015. Garcinielliptone FC: antiparasitic activity without cytotoxicity to mammalian cells. Toxicol In Vitro 29:681–687. doi: 10.1016/j.tiv.2014.12.014. [DOI] [PubMed] [Google Scholar]
  • 25.de Moraes J, Almeida AA, Brito MR, Marques TH, Lima TC, Sousa DP, Nakano E, Mendonça RZ, Freitas RM. 2013. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni. Planta Med 79:253–258. doi: 10.1055/s-0032-1328173. [DOI] [PubMed] [Google Scholar]
  • 26.de Moraes J, Nascimento C, Lopes PO, Nakano E, Yamaguchi LF, Kato MJ, Kawano T. 2011. Schistosoma mansoni: in vitro schistosomicidal activity of piplartine. Exp Parasitol 127:357–364. doi: 10.1016/j.exppara.2010.08.021. [DOI] [PubMed] [Google Scholar]
  • 27.El Ridi R, Aboueldahab M, Tallima H, Salah M, Mahana N, Fawzi S, Mohamed SH, Fahmy OM. 2010. In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium. Antimicrob Agents Chemother 54:3383–3389. doi: 10.1128/AAC.00173-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Manneck T, Haggenmüller Y, Keiser J. 2010. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137:85–98. doi: 10.1017/S0031182009990965. [DOI] [PubMed] [Google Scholar]
  • 29.de Moraes J, Nascimento C, Miura LM, Leite JR, Nakano E. 2011. Evaluation of the in vitro activity of dermaseptin 01, a cationic antimicrobial peptide, against Schistosoma mansoni. Chem Biodivers 8:548–558. doi: 10.1002/cbdv.201000163. [DOI] [PubMed] [Google Scholar]
  • 30.Borges BE, Teixeira VR, Appel MH, Steclan CA, Rigo F, Filipak Neto F, da Costa Ferreira AM, Chammas R, Zanata SM, Nakao LS. 2013. De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus. Chem Biol Interact 206:37–46. doi: 10.1016/j.cbi.2013.08.005. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES